NNBP (NNBP) Stock Price & Analysis
NNBP (NNBP) rose 0.00% to USD 0 as of June 10, 2026 at 07:34 UTC, according to Nexqual real-time market data.
NNBP last closed at USD 0; the session ranged USD 0–0 on volume of 1,000 shares. Market capitalization is $124,752, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 07:34 UTC.
Key Statistics (as of June 10, 2026 at 07:34 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 1,000 shares |
| Market Cap | $124,752 |
| Exchange | PNK |
Technical Analysis (NNBP)
Nexqual's technical model rates NNBP "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:34 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (NNBP)
Wall Street analysts rate NNBP "None", per Nexqual as of June 10, 2026 at 07:34 UTC.
| Consensus Rating | None |
|---|
Earnings (NNBP)
Source: Nexqual, June 10, 2026 at 07:34 UTC.
Financials & Fundamentals (NNBP)
| Total Revenue | $17,621 |
|---|---|
| Revenue Growth (YoY) | +86.60% |
| Gross Margin | +17.60% |
| Operating Margin | -15142.10% |
| Profit Margin | +0.00% |
| Current Ratio | 0.01 |
| Total Cash | $3,933 |
| Total Debt | $4.12M |
| Free Cash Flow | $1.03M |
Source: Nexqual, June 10, 2026 at 07:34 UTC.
Financial Health Score (NNBP)
Nexqual rates NNBP's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:34 UTC.
| Growth | Strong — Revenue +87% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $4K cash vs $4M debt |
| Cash Flow | Strong — FCF $1M, 5856% margin |
| Efficiency | Mixed — No data |
Ownership (NNBP)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 0 |
Source: Nexqual, June 10, 2026 at 07:34 UTC.
Leadership (NNBP)
NNBP is led by John M. Stanton (age 62), Chairman, CEO, CFO & Principal Accounting Officer, per Nexqual as of June 10, 2026 at 07:34 UTC.
| Chairman, CEO, CFO & Principal Accounting Officer | John M. Stanton (age 62) |
|---|---|
| Director of Clinical Research, Medical Director & Director | Benedict Salvadore Maniscalco (age 83) |
| Co-Founder, Director of Science & Scientific Advisor | Neva Ciftcioglu |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| USGA | US GLOBAL NANOSPACE INC | USD 0 | ▲ 0% |
| NPCT | 102479 | USD 9.92 | ▲ 0.2% |
| BIPH | Brookfield Infrastructure Corpo | USD 16.34 | ▲ 0% |
| SLSN | Solesence, Inc. | USD 1.22 | ▼ 6.87% |
| MRPI | MERA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:34 UTC. This page is informational and not investment advice.